Full-Time

AI Security Manager / Architect

Posted on 2/28/2026

Philips

Philips

Manufactures sleep therapy and respiratory devices

No salary listed

Bengaluru, Karnataka, India

In Person

On-site role; full-time in-office presence required (minimum 3 days/week for office-based teams) in Bangalore.

Category
IT & Security (1)
Required Skills
LLM
Microsoft Azure
RAG
AWS
Cryptography
REST APIs
Databricks
Google Cloud Platform
Requirements
  • Minimum 12+ years of experience in cybersecurity or information security.
  • At least 6+ years in enterprise security architecture roles.
  • Demonstrated experience securing AI platforms.
  • Strong knowledge of cloud platforms including Microsoft Azure, AWS, or Google Cloud.
  • Experience designing security architecture for modern data and AI platforms.
Responsibilities
  • Design and maintain the enterprise AI Security Reference Architecture aligned with enterprise architecture frameworks.
  • The architecture will define secure patterns for machine learning pipelines, data pipelines, model training environments, inference services, and Generative AI platforms deployed across Philips.
  • Support modern AI platforms such as Azure OpenAI, AWS BedRock, Google Gemini AI, and Databricks ML environments while ensuring secure integration with enterprise data platforms and applications.
  • Secure design principles such as Zero Trust for AI systems, model isolation, secure API integrations, and protected AI workloads will be incorporated into enterprise architecture standards.
  • Define enterprise security controls for AI and Generative AI environments including secure model registries, model artifact integrity validation, cryptographic model signing, and verification of model provenance.
  • The architect will establish security guardrails for Large Language Model (LLM) deployments including prompt injection protection, output filtering, content moderation, protection against sensitive data leakage, and secure implementation of Retrieval Augmented Generation (RAG) architectures.
  • Address emerging risks such as model extraction, adversarial attacks, and inference manipulation.
  • Establish governance models for enterprise use of foundation models and generative AI technologies.
  • Define architectural guardrails for AI orchestration frameworks and implement safety mechanisms.
  • Governance policies will ensure responsible AI usage, secure prompt management, and compliance with enterprise data protection requirements.
  • Lead AI threat modeling and risk assessments using frameworks such as MITRE ATLAS, OWASP Top 10 for LLM Applications, and the NIST AI Risk Management Framework.
  • Address advanced AI security areas including AI supply chain security, model provenance verification, and security controls for autonomous AI agents.
  • Design monitoring capabilities for AI systems to ensure continuous oversight of model behavior, performance, and security posture.
  • Ensure that enterprise AI systems comply with global healthcare regulatory requirements including the EU AI Act.
  • Support regulatory expectations for explainability, transparency, fairness, auditability, and human oversight in AI-driven systems.
  • Establish and lead an enterprise AI Security Center of Excellence responsible for defining AI security standards, architecture guidelines, security testing practices, and governance processes.
  • Develop and maintain an enterprise AI Security Maturity Model that guides the organization’s journey toward secure AI adoption focusing on automated monitoring, continuous model validation, and AI-driven security analytics across enterprise AI platforms.
  • This role will collaborate with Global AI Center of Practice to ensure that AI innovation aligns with patient safety, regulatory compliance, and enterprise security standards.
Desired Qualifications
  • Preferred AI Security Tooling such as Lakera, ProtectAI, HiddenLayer, NVIDIA AI security stack, Garak LLM vulnerability scanner, and Microsoft PyRIT for AI red teaming is highly desirable.
  • Preferred Certifications: CISSP, CCSP, SABSA, or ISSAP certifications are preferred. Additional certifications in AI governance, Responsible AI, cloud security architecture, or AI risk management are considered an advantage.

Philips Respironics designs sleep and respiratory care devices, including CPAP and BiPAP machines, ventilators, and oxygen concentrators, plus related systems. These devices deliver regulated air pressure, support or assist breathing, and provide concentrated oxygen, often paired with software and data tools for monitoring. The division differentiates itself through its long history within Philips and its integrated ecosystem that connects devices with analytics and clinical support across hospital, clinic, and home settings. Its goal is to improve quality of life and clinical outcomes for people with sleep and respiratory conditions by offering reliable devices, patient support, and data-driven care.

Company Size

N/A

Company Stage

Acquired

Total Funding

$5.1B

Headquarters

Murrysville, Pennsylvania

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • BioTelemetry acquisition in 2020 expands remote heart monitoring.
  • $479 million settlement in September 2023 closes US litigation.
  • New silicone foam validated safe, enabling global device sales.

What critics are saying

  • ResMed seizes US sleep market share within 6-12 months.
  • FDA consent decree blocks US sales until after 2026.
  • January 2024 US ventilation exit halves revenue permanently.

What makes Philips unique

  • Pioneered CPAP therapy as standard for sleep apnea since 1976.
  • Leads in non-invasive ventilation and home respiratory support.
  • Integrates devices with software for data-driven clinical outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

Parker Waichman LLP
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

VentureBeat
Oct 26th, 2022
Philips Norelco Brings Movember To Roblox With Shavetopia

Register now for your free virtual pass to the Low-Code/No-Code Summit this November 9. Hear from executives from Service Now, Credit Karma, Stitch Fix, Appian, and more. Learn more. Philips Norelco is creating an interactive metaverse experience called Shavetopia in Roblox, based around the Movember trend. For anyone who doesn’t know what that is, Movember is where people grow facial hair for the entire month of November. The portmanteau comes from adding the word mustache to the name of the month

INACTIVE